Precision Biosciences (DTIL) Debt Ratio (2021 - 2025)
Precision Biosciences (DTIL) has disclosed Debt Ratio for 4 consecutive years, with 0.24 as the latest value for Q3 2025.
- On a quarterly basis, Debt Ratio rose 64.6% to 0.24 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.24, a 64.6% increase, with the full-year FY2024 number at 0.16, up 16.68% from a year prior.
- Debt Ratio was 0.24 for Q3 2025 at Precision Biosciences, up from 0.21 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.24 in Q3 2025 to a low of 0.01 in Q2 2021.
- A 4-year average of 0.13 and a median of 0.14 in 2023 define the central range for Debt Ratio.
- Peak YoY movement for Debt Ratio: rose 6.82% in 2024, then soared 64.6% in 2025.
- Precision Biosciences' Debt Ratio stood at 0.01 in 2021, then soared by 1198.64% to 0.14 in 2023, then rose by 16.68% to 0.16 in 2024, then surged by 46.2% to 0.24 in 2025.
- Per Business Quant, the three most recent readings for DTIL's Debt Ratio are 0.24 (Q3 2025), 0.21 (Q2 2025), and 0.18 (Q1 2025).